Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (<35 years, 35 years, >35 years) – 2018 Edition: Forecast to 2022
Executive Summary
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of global cervical cancer diagnostics market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (Below 35 years and 35 years & above), By Region (North America, Europe, Asia Pacific and Rest of the World) and By Country (U.S, Canada, Germany, U.K, China, India, Mexico and Brazil).
According to Azoth Analytics research report, “Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (35 years, 35 years, >35 years) – 2018 Edition: Forecast to 2022”, global market is projected to display a modest growth represented by a CAGR of 5.69% during 2017 – 2022, chiefly driven by growing healthcare awareness and increasing expenditure in healthcare sector.
On account of growing urbanization, there has been rising awareness regarding the benefits of periodic screening for cervical cancer. Additionally, growing female population in concurrence with medical infrastructural developments in emerging economies has been instrumental in boosting the demand for cervical cancer diagnostics. Amongst the type of cervical cancer diagnostic tests, cytology based screening solutions such as Pap and HPV, held the majority market share of more than 50%, by value, in the year 2016. Moreover, HPV tests are gaining market share on account of advantageous characteristics such as reliable and accurate result, reasonable cost, longer time gap between tests, and so on. Among the regions, North America and Europe together represents the largest regional market for global cervical cancer diagnostics market, chiefly driven by high per capita expenditure on healthcare, as well as availability of advanced medical infrastructure.
The report titled, “Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (35 years, 35 years, >35 years) – 2018 Edition: Forecast to 2022”, has covered and analysed the potential of cervical cancer diagnostics market across the globe and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global cervical cancer diagnostics market. Additionally, the report also highlights market entry strategies for various companies across the globe.
Scope of the Report
Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of global cervical cancer diagnostics market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (Below 35 years and 35 years & above), By Region (North America, Europe, Asia Pacific and Rest of the World) and By Country (U.S, Canada, Germany, U.K, China, India, Mexico and Brazil).
According to Azoth Analytics research report, “Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (35 years, 35 years, >35 years) – 2018 Edition: Forecast to 2022”, global market is projected to display a modest growth represented by a CAGR of 5.69% during 2017 – 2022, chiefly driven by growing healthcare awareness and increasing expenditure in healthcare sector.
On account of growing urbanization, there has been rising awareness regarding the benefits of periodic screening for cervical cancer. Additionally, growing female population in concurrence with medical infrastructural developments in emerging economies has been instrumental in boosting the demand for cervical cancer diagnostics. Amongst the type of cervical cancer diagnostic tests, cytology based screening solutions such as Pap and HPV, held the majority market share of more than 50%, by value, in the year 2016. Moreover, HPV tests are gaining market share on account of advantageous characteristics such as reliable and accurate result, reasonable cost, longer time gap between tests, and so on. Among the regions, North America and Europe together represents the largest regional market for global cervical cancer diagnostics market, chiefly driven by high per capita expenditure on healthcare, as well as availability of advanced medical infrastructure.
The report titled, “Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (35 years, 35 years, >35 years) – 2018 Edition: Forecast to 2022”, has covered and analysed the potential of cervical cancer diagnostics market across the globe and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global cervical cancer diagnostics market. Additionally, the report also highlights market entry strategies for various companies across the globe.
Scope of the Report
Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)
- Global Cervical Cancer Diagnostics Market, By Value
- Global Cervical Cancer Diagnostics Market, By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Value
- Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years and 35 years and above), By Value
- Cervical Cancer Diagnostics Market, By Value
- Cervical Cancer Diagnostics Market, By Type, By Value
- Cervical Cancer Diagnostics Market, By Age Group, By Value
- Cervical Cancer Diagnostics Market, By Value
- Cervical Cancer Diagnostics Market, By Type, By Value
- Cervical Cancer Diagnostics Market, By Age Group, By Value
- Market Dynamics – Trends, Drivers, Restraints
- Porter Five Force Analysis
- SWOT Analysis
- Supply Chain Analysis
- Pricing Analysis
- Product Benchmarking of Key Industry Players
- Recent Product Approvals of Key Industry Players
- Policy and Regulation
- Company Analysis – Hologic, Roche, Abott Laboratories, Guided Therapeutics, Becton, Dickinson and Company, Qiagen, Quest Diagnostics, Arbor Vita Corporation.
- Company Share Analysis
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
1. RESEARCH METHODOLOGY
2. EXECUTIVE SUMMARY
3. STRATEGIC RECOMMENDATIONS
4. CERVICAL CANCER OUTLOOK
5. GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET: GROWTH AND FORECAST
5.1. By Value (2012-2016)
5.2. By Value (2012-2016)
6. GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET: AN ANALYSIS
6.1. Global Cervical Cancer Diagnostics Market Size, By Type
6.1.1. Global Cervical Cancer Diagnostics Market Size, By Type, 2016 (%)
6.1.2. Global Cervical Cancer Diagnostics Market Size, By Type, 2022 (%)
6.1.3. Global Pap Test Market, By Value (2012-2022)
6.1.4. Global HPV Test Market, By Value (2012-2022)
6.1.5. Global Colposcopy Market, By Value (2012-2022)
6.1.6. Global Cervical Biopsies Market, By Value (2012-2022)
6.2. Global Cervical Cancer Diagnostics Market Size, By Age Group
6.2.1. Global Cervical Cancer Diagnostics Market Size, By Age Group, 2016 (%)
6.2.2. Global Cervical Cancer Diagnostics Market Size, By Age Group, 2022 (%)
6.2.3. Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value (2012-2022)
6.2.4. Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above),
6.2.5. By Value (2012-2022)
7. GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET: REGIONAL ANALYSIS
7.1. Global Cervical Cancer Diagnostics Market Size, By Region: Breakdown (%)
7.1.1. Global Cervical Cancer Diagnostics Market Size, By Region, 2016 (%)
7.1.2. Global Cervical Cancer Diagnostics Market Size, By Region, 2022 (%)
7.2. North America Cervical Cancer Diagnostics Market: An Analysis
7.2.1. By Value (2012-2016)
7.2.2. By Value (2017-2022)
7.2.3. By Type, By Value (2012-2022)
7.2.4. By Age Group, By Value (2012-2022)
7.3. North America Cervical Cancer Diagnostics Market: Country Analysis (U.S and Canada)
7.3.1. U.S Cervical Cancer Diagnostics Market, By Value (2012-2022)
7.3.2. U.S Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
7.3.3. U.S Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
7.3.4. Canada Cervical Cancer Diagnostics Market, By Value (2012-2022)
7.3.5. Canada Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
7.3.6. Canada Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
7.4. Europe Cervical Cancer Diagnostics Market: An Analysis
7.4.1. By Value (2012-2016)
7.4.2. By Value (2017-2022)
7.4.3. By Type, By Value (2012-2022)
7.4.4. By Age Group, By Value (2012-2022)
7.5. Europe Cervical Cancer Diagnostics Market: Country Analysis (Germany and U.K)
7.5.1. Germany Cervical Cancer Diagnostics Market, By Value (2012-2022)
7.5.2. Germany Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
7.5.3. Germany Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
7.5.4. U.K Cervical Cancer Diagnostics Market, By Value (2012-2022)
7.5.5. U.K Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
7.5.6. U.K Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
7.6. APAC Cervical Cancer Diagnostics Market: An Analysis
7.6.1. By Value (2012-2016)
7.6.2. By Value (2017-2022)
7.6.3. By Type, By Value (2012-2022)
7.6.4. By Age Group, By Value (2012-2022)
7.7. APAC Cervical Cancer Diagnostics Market: Country Analysis (China and India)
7.7.1. China Cervical Cancer Diagnostics Market, By Value (2012-2022)
7.7.2. China Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
7.7.3. China Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
7.7.4. India Cervical Cancer Diagnostics Market, By Value (2012-2022)
7.7.5. India Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
7.7.6. India Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
7.8. ROW Cervical Cancer Diagnostics Market: An Analysis
7.8.1. By Value (2012-2016)
7.8.2. By Value (2017-2022)
7.8.3. By Type, By Value (2012-2022)
7.8.4. By Age Group, By Value (2012-2022)
7.9. ROW Cervical Cancer Diagnostics Market: Country Analysis (Brazil and Mexico)
7.9.1. Brazil Cervical Cancer Diagnostics Market, By Value (2012-2022)
7.9.2. Brazil Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
7.9.3. Brazil Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
7.9.4. Mexico Cervical Cancer Diagnostics Market, By Value (2012-2022)
7.9.5. Mexico Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
7.9.6. Mexico Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
8. GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET DYNAMICS
8.1. Global Cervical Cancer Diagnostics Market Drivers
8.2. Global Cervical Cancer Diagnostics Market Restraints
9. GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET TRENDS
10. PORTER FIVE FORCE ANALYSIS
11. SWOT ANALYSIS
12. SUPPLY CHAIN ANALYSIS
13. PRICING ANALYSIS
14. COMPETITIVE LANDSCAPE
14.1. Company Share Analysis of Key Industry Players
14.2. Product Benchmarking of Key Industry Players
14.3. Recent Product Approvals of Key Industry Players
15. POLICY AND REGULATORY LANDSCAPE
16. COMPANY PROFILES
16.1. Hologic
16.2. Abott Laboratories
16.3. Roche
16.4. Guided Therapeutics
16.5. Becton, Dickinson and Company
16.6. Qiagen
16.7. Quest Diagnostics
16.8. Arbor Vita Corporation
17. ABOUT US
2. EXECUTIVE SUMMARY
3. STRATEGIC RECOMMENDATIONS
4. CERVICAL CANCER OUTLOOK
5. GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET: GROWTH AND FORECAST
5.1. By Value (2012-2016)
5.2. By Value (2012-2016)
6. GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET: AN ANALYSIS
6.1. Global Cervical Cancer Diagnostics Market Size, By Type
6.1.1. Global Cervical Cancer Diagnostics Market Size, By Type, 2016 (%)
6.1.2. Global Cervical Cancer Diagnostics Market Size, By Type, 2022 (%)
6.1.3. Global Pap Test Market, By Value (2012-2022)
6.1.4. Global HPV Test Market, By Value (2012-2022)
6.1.5. Global Colposcopy Market, By Value (2012-2022)
6.1.6. Global Cervical Biopsies Market, By Value (2012-2022)
6.2. Global Cervical Cancer Diagnostics Market Size, By Age Group
6.2.1. Global Cervical Cancer Diagnostics Market Size, By Age Group, 2016 (%)
6.2.2. Global Cervical Cancer Diagnostics Market Size, By Age Group, 2022 (%)
6.2.3. Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value (2012-2022)
6.2.4. Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above),
6.2.5. By Value (2012-2022)
7. GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET: REGIONAL ANALYSIS
7.1. Global Cervical Cancer Diagnostics Market Size, By Region: Breakdown (%)
7.1.1. Global Cervical Cancer Diagnostics Market Size, By Region, 2016 (%)
7.1.2. Global Cervical Cancer Diagnostics Market Size, By Region, 2022 (%)
7.2. North America Cervical Cancer Diagnostics Market: An Analysis
7.2.1. By Value (2012-2016)
7.2.2. By Value (2017-2022)
7.2.3. By Type, By Value (2012-2022)
7.2.4. By Age Group, By Value (2012-2022)
7.3. North America Cervical Cancer Diagnostics Market: Country Analysis (U.S and Canada)
7.3.1. U.S Cervical Cancer Diagnostics Market, By Value (2012-2022)
7.3.2. U.S Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
7.3.3. U.S Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
7.3.4. Canada Cervical Cancer Diagnostics Market, By Value (2012-2022)
7.3.5. Canada Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
7.3.6. Canada Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
7.4. Europe Cervical Cancer Diagnostics Market: An Analysis
7.4.1. By Value (2012-2016)
7.4.2. By Value (2017-2022)
7.4.3. By Type, By Value (2012-2022)
7.4.4. By Age Group, By Value (2012-2022)
7.5. Europe Cervical Cancer Diagnostics Market: Country Analysis (Germany and U.K)
7.5.1. Germany Cervical Cancer Diagnostics Market, By Value (2012-2022)
7.5.2. Germany Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
7.5.3. Germany Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
7.5.4. U.K Cervical Cancer Diagnostics Market, By Value (2012-2022)
7.5.5. U.K Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
7.5.6. U.K Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
7.6. APAC Cervical Cancer Diagnostics Market: An Analysis
7.6.1. By Value (2012-2016)
7.6.2. By Value (2017-2022)
7.6.3. By Type, By Value (2012-2022)
7.6.4. By Age Group, By Value (2012-2022)
7.7. APAC Cervical Cancer Diagnostics Market: Country Analysis (China and India)
7.7.1. China Cervical Cancer Diagnostics Market, By Value (2012-2022)
7.7.2. China Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
7.7.3. China Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
7.7.4. India Cervical Cancer Diagnostics Market, By Value (2012-2022)
7.7.5. India Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
7.7.6. India Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
7.8. ROW Cervical Cancer Diagnostics Market: An Analysis
7.8.1. By Value (2012-2016)
7.8.2. By Value (2017-2022)
7.8.3. By Type, By Value (2012-2022)
7.8.4. By Age Group, By Value (2012-2022)
7.9. ROW Cervical Cancer Diagnostics Market: Country Analysis (Brazil and Mexico)
7.9.1. Brazil Cervical Cancer Diagnostics Market, By Value (2012-2022)
7.9.2. Brazil Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
7.9.3. Brazil Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
7.9.4. Mexico Cervical Cancer Diagnostics Market, By Value (2012-2022)
7.9.5. Mexico Cervical Cancer Diagnostics Market, By Type, By Value (2012-2022)
7.9.6. Mexico Cervical Cancer Diagnostics Market, By Age Group, By Value (2012-2022)
8. GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET DYNAMICS
8.1. Global Cervical Cancer Diagnostics Market Drivers
8.2. Global Cervical Cancer Diagnostics Market Restraints
9. GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET TRENDS
10. PORTER FIVE FORCE ANALYSIS
11. SWOT ANALYSIS
12. SUPPLY CHAIN ANALYSIS
13. PRICING ANALYSIS
14. COMPETITIVE LANDSCAPE
14.1. Company Share Analysis of Key Industry Players
14.2. Product Benchmarking of Key Industry Players
14.3. Recent Product Approvals of Key Industry Players
15. POLICY AND REGULATORY LANDSCAPE
16. COMPANY PROFILES
16.1. Hologic
16.2. Abott Laboratories
16.3. Roche
16.4. Guided Therapeutics
16.5. Becton, Dickinson and Company
16.6. Qiagen
16.7. Quest Diagnostics
16.8. Arbor Vita Corporation
17. ABOUT US
LIST OF FIGURES
Figure 1: Global Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)
Figure 2: Global Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 3: Healthcare Costs Per Capita, By Select Countries, 2015 (USD)
Figure 4: World Female Population Estimates, 2017 (In Millions)
Figure 5: Age-Standardized Cervical Cancer Incidence Rate (per 100,000 women per year), By Region
Figure 6: Top 10 Most Frequent Cancer in Females, World, (Age-standardised incidence rate per 100,000 women)
Figure 7: Top 10 Most Frequent Cancer Deaths in Females, World, (Age-standardised incidence rate per 100,000 women)
Figure 8: Global Cervical Cancer Diagnostics Market Size, By Type, 2016 (%)
Figure 9: Global Cervical Cancer Diagnostics Market Size, By Type, 2022 (%)
Figure 10: Global PAP Test Market, By Value, 2012-2016 (USD Million)
Figure 11: Global PAP Test Market, By Value, Forecast, 2017-2022 (USD Million)
Figure 12: Global HPV Test Market, By Value, 2012-2016 (USD Million)
Figure 13: Global HPV Test Market, By Value, Forecast, 2017-2022 (USD Million)
Figure 14: Global Colposcopy Test Market, By Value, 2012-2016 (USD Million)
Figure 15: Global Colposcopy Test Market, By Value, Forecast, 2017-2022 (USD Million)
Figure 16: Global Cervical Biopsies Market, By Value, 2012-2016 (USD Million)
Figure 17: Global Cervical Biopsies Market, By Value, Forecast, 2017-2022, (USD Million)
Figure 18: Global Cervical Cancer Diagnostics Market Size, By Age Group, 2016 (%)
Figure 19: Global Cervical Cancer Diagnostics Market Size, By Age Group, 2022 (%)
Figure 20: Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value, 2012-2016 (USD Million)
Figure 21: Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value, Forecast, 2017-2022 (USD Million)
Figure 22: Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above), By Value, 2012-2016 (USD Million)
Figure 23: Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above), By Value, Forecast, 2017-2022 (USD Million)
Figure 24: Global Cervical Cancer Diagnostics Market Size, By Region, 2016 (%)
Figure 25: Global Cervical Cancer Diagnostics Market Size, By Region, 2022 (%)
Figure 26: North America Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)
Figure 27: North America Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 28: North America Healthcare Cost Per Capita, By Select Country, 2016 (USD)
Figure 29: North America GDP, 2012-2015 (USD Trillion)
Figure 30: North America GDP, By Select Country, 2016 (USD Trillion)
Figure 31: United States of America, Per Capita Expenditure on Healthcare, 2012-2016 (USD)
Figure 32: Canada, Per Capita Expenditure on Healthcare, 2012-2016 (USD)
Figure 33: United States of America, Female Population in the age group 15-64, 2012-2016
Figure 34: Canada, Female Population in the age group 15-64, 2012-2016
Figure 35: North America Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 36: North America Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 37: U.S. Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
Figure 38: U.S Health Spending, By Service or Product, 2016 (%)
Figure 39: U.S Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 40: U.S Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 41: Canada Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
Figure 42: Canada Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 43: Canada Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 44: North America Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total)
Figure 45: North America Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total)
Figure 46: Europe Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)
Figure 47: Europe Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 48: Europe, GDP, By Select Country, 2016, (USD Billion)
Figure 49: Europe Health Spending Per Capita, By Select Country, 2016 (USD)
Figure 50: United Kingdom, Per Capita Expenditure on Healthcare, 2012-2016 (USD)
Figure 51: Germany, Per Capita Expenditure on Healthcare, 2012-2016 (USD)
Figure 52: United Kingdom, Female Population in the age group 15-64, 2012-2016
Figure 53: Germany, Female Population in the age group 15-64, 2012-2016
Figure 54: Europe Medical Technology Market Based on Manufacturer Prices, By Country, 2016 (%)
Figure 55: Europe Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 56: Europe Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 57: Germany Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
Figure 58: Germany Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 59: Germany Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 60: U.K Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
Figure 61: U.K Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 62: U.K Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 63: Europe Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total)
Figure 64: Europe Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total)
Figure 65: APAC Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)
Figure 66: APAC Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 67: APAC, GDP, By Select Country, 2016, (USD Billion)
Figure 68: APAC Health Expenditure Per Capita, Public and Private, By Select Country, 2016 (USD)
Figure 69: China, Female Population in the age group 15-64, 2012-2016
Figure 70: India, Female Population in the age group 15-64, 2012-2016
Figure 71: India, Degree of Urbanization, 2012-2016 (in %)
Figure 72: China, Degree of Urbanization, 2012-2016, (in %)
Figure 73: APAC Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 74: APAC Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 75: China Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
Figure 76: China Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 77: China Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 78: India Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
Figure 79: India Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 80: India Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 81: APAC Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total)
Figure 82: APAC Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total)
Figure 83: ROW Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)
Figure 84: ROW Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 85: ROW Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 86: Brazil Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
Figure 87: Brazil, Female Population in the age group 15-64, 2012-2016
Figure 88: Brazil, Degree of Urbanization, 2012-2016 (in %)
Figure 89: Brazil Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 90: Brazil Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 91: Mexico Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
Figure 92: Mexico, Female Population in the age group 15-64, 2012-2016
Figure 93: Mexico, Degree of Urbanization, 2012-2016 (in %)
Figure 94: Mexico Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 95: Mexico Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 96: ROW Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total)
Figure 97: ROW Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total)
Figure 98: Global Cervical Cancer Diagnostics Market, By Company Share, 2016 (%)
Figure 99: Hologic, Revenue, 2013-2017 (USD Billion)
Figure 100: Hologic, Revenue, By Geography, 2017 (%)
Figure 101: Hologic, Revenue, By Segment, 2017 (%)
Figure 102: Abbott Laboratories, Revenue, 2012-2016 (USD Million)
Figure 103: Abobott Laboratories, Revenue, By Segment, 2016 (%)
Figure 104: Abbott, Revenue, By Geography, 2016 (%)
Figure 105: Roche, Revenue, 2012-2016 (USD Million)
Figure 106: Roche, Revenue, By Segment, 2016 (%)
Figure 107: Roche, Revenue, By Segment, 2016 (%)
Figure 108: Guided Therapeutics, Sales, 2012-2016 (USD thousands)
Figure 109: BD, Revenue, 2012-2016 (USD Million)
Figure 110: BD, Revenue, By geography, 2017 (%)
Figure 111: BD, Revenue, By Segment, 2017 (%)
Figure 112: Qiagen, Revenue, 2012-2016 (USD Millions)
Figure 113: Qiagen, Revenue, By geography, 2016 (%)
Figure 114: Qiagen, Revenue, By Product Categories, 2016 (%)
Figure 115: Quest Diagnostics, Revenue, 2012-2016 (USD Millions)
Figure 116: Qiagen, Revenue, By Business Segments, 2016
Figure 1: Global Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)
Figure 2: Global Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 3: Healthcare Costs Per Capita, By Select Countries, 2015 (USD)
Figure 4: World Female Population Estimates, 2017 (In Millions)
Figure 5: Age-Standardized Cervical Cancer Incidence Rate (per 100,000 women per year), By Region
Figure 6: Top 10 Most Frequent Cancer in Females, World, (Age-standardised incidence rate per 100,000 women)
Figure 7: Top 10 Most Frequent Cancer Deaths in Females, World, (Age-standardised incidence rate per 100,000 women)
Figure 8: Global Cervical Cancer Diagnostics Market Size, By Type, 2016 (%)
Figure 9: Global Cervical Cancer Diagnostics Market Size, By Type, 2022 (%)
Figure 10: Global PAP Test Market, By Value, 2012-2016 (USD Million)
Figure 11: Global PAP Test Market, By Value, Forecast, 2017-2022 (USD Million)
Figure 12: Global HPV Test Market, By Value, 2012-2016 (USD Million)
Figure 13: Global HPV Test Market, By Value, Forecast, 2017-2022 (USD Million)
Figure 14: Global Colposcopy Test Market, By Value, 2012-2016 (USD Million)
Figure 15: Global Colposcopy Test Market, By Value, Forecast, 2017-2022 (USD Million)
Figure 16: Global Cervical Biopsies Market, By Value, 2012-2016 (USD Million)
Figure 17: Global Cervical Biopsies Market, By Value, Forecast, 2017-2022, (USD Million)
Figure 18: Global Cervical Cancer Diagnostics Market Size, By Age Group, 2016 (%)
Figure 19: Global Cervical Cancer Diagnostics Market Size, By Age Group, 2022 (%)
Figure 20: Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value, 2012-2016 (USD Million)
Figure 21: Global Cervical Cancer Diagnostics Market, By Age Group (Below 35 years), By Value, Forecast, 2017-2022 (USD Million)
Figure 22: Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above), By Value, 2012-2016 (USD Million)
Figure 23: Global Cervical Cancer Diagnostics Market, By Age Group (35 years and above), By Value, Forecast, 2017-2022 (USD Million)
Figure 24: Global Cervical Cancer Diagnostics Market Size, By Region, 2016 (%)
Figure 25: Global Cervical Cancer Diagnostics Market Size, By Region, 2022 (%)
Figure 26: North America Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)
Figure 27: North America Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 28: North America Healthcare Cost Per Capita, By Select Country, 2016 (USD)
Figure 29: North America GDP, 2012-2015 (USD Trillion)
Figure 30: North America GDP, By Select Country, 2016 (USD Trillion)
Figure 31: United States of America, Per Capita Expenditure on Healthcare, 2012-2016 (USD)
Figure 32: Canada, Per Capita Expenditure on Healthcare, 2012-2016 (USD)
Figure 33: United States of America, Female Population in the age group 15-64, 2012-2016
Figure 34: Canada, Female Population in the age group 15-64, 2012-2016
Figure 35: North America Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 36: North America Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 37: U.S. Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
Figure 38: U.S Health Spending, By Service or Product, 2016 (%)
Figure 39: U.S Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 40: U.S Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 41: Canada Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
Figure 42: Canada Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 43: Canada Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 44: North America Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total)
Figure 45: North America Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total)
Figure 46: Europe Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)
Figure 47: Europe Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 48: Europe, GDP, By Select Country, 2016, (USD Billion)
Figure 49: Europe Health Spending Per Capita, By Select Country, 2016 (USD)
Figure 50: United Kingdom, Per Capita Expenditure on Healthcare, 2012-2016 (USD)
Figure 51: Germany, Per Capita Expenditure on Healthcare, 2012-2016 (USD)
Figure 52: United Kingdom, Female Population in the age group 15-64, 2012-2016
Figure 53: Germany, Female Population in the age group 15-64, 2012-2016
Figure 54: Europe Medical Technology Market Based on Manufacturer Prices, By Country, 2016 (%)
Figure 55: Europe Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 56: Europe Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 57: Germany Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
Figure 58: Germany Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 59: Germany Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 60: U.K Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
Figure 61: U.K Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 62: U.K Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 63: Europe Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total)
Figure 64: Europe Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total)
Figure 65: APAC Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)
Figure 66: APAC Cervical Cancer Diagnostics Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 67: APAC, GDP, By Select Country, 2016, (USD Billion)
Figure 68: APAC Health Expenditure Per Capita, Public and Private, By Select Country, 2016 (USD)
Figure 69: China, Female Population in the age group 15-64, 2012-2016
Figure 70: India, Female Population in the age group 15-64, 2012-2016
Figure 71: India, Degree of Urbanization, 2012-2016 (in %)
Figure 72: China, Degree of Urbanization, 2012-2016, (in %)
Figure 73: APAC Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 74: APAC Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 75: China Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
Figure 76: China Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 77: China Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 78: India Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
Figure 79: India Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 80: India Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 81: APAC Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total)
Figure 82: APAC Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total)
Figure 83: ROW Cervical Cancer Diagnostics Market Size, By Value, 2012-2016 (USD Million)
Figure 84: ROW Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 85: ROW Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 86: Brazil Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
Figure 87: Brazil, Female Population in the age group 15-64, 2012-2016
Figure 88: Brazil, Degree of Urbanization, 2012-2016 (in %)
Figure 89: Brazil Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 90: Brazil Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 91: Mexico Cervical Cancer Diagnostics Market Size, By Value, 2012-2022 (USD Million)
Figure 92: Mexico, Female Population in the age group 15-64, 2012-2016
Figure 93: Mexico, Degree of Urbanization, 2012-2016 (in %)
Figure 94: Mexico Cervical Cancer Diagnostics Market: By Type, By Value, 2012-2022 (USD Million)
Figure 95: Mexico Cervical Cancer Diagnostics Market: By Age Group, By Value, 2012-2022 (USD Million)
Figure 96: ROW Cervical Cancer Diagnostics Market, Country Share, 2012-2016 (% of Total)
Figure 97: ROW Cervical Cancer Diagnostics Market, Country Share, Forecast, 2017-2022 (% of Total)
Figure 98: Global Cervical Cancer Diagnostics Market, By Company Share, 2016 (%)
Figure 99: Hologic, Revenue, 2013-2017 (USD Billion)
Figure 100: Hologic, Revenue, By Geography, 2017 (%)
Figure 101: Hologic, Revenue, By Segment, 2017 (%)
Figure 102: Abbott Laboratories, Revenue, 2012-2016 (USD Million)
Figure 103: Abobott Laboratories, Revenue, By Segment, 2016 (%)
Figure 104: Abbott, Revenue, By Geography, 2016 (%)
Figure 105: Roche, Revenue, 2012-2016 (USD Million)
Figure 106: Roche, Revenue, By Segment, 2016 (%)
Figure 107: Roche, Revenue, By Segment, 2016 (%)
Figure 108: Guided Therapeutics, Sales, 2012-2016 (USD thousands)
Figure 109: BD, Revenue, 2012-2016 (USD Million)
Figure 110: BD, Revenue, By geography, 2017 (%)
Figure 111: BD, Revenue, By Segment, 2017 (%)
Figure 112: Qiagen, Revenue, 2012-2016 (USD Millions)
Figure 113: Qiagen, Revenue, By geography, 2016 (%)
Figure 114: Qiagen, Revenue, By Product Categories, 2016 (%)
Figure 115: Quest Diagnostics, Revenue, 2012-2016 (USD Millions)
Figure 116: Qiagen, Revenue, By Business Segments, 2016
LIST OF TABLES
Table A: List of Abbreviations
Table B: Cervical Cancer Flowchart
Table C: Cervical Cancer Screening Recommendations
Table D: Cervical Cancer Diagnostics Segmentation Flowchart
Table E: Medical Tourism Market Drivers
Table F: Medical Tourism Index, By Region and Top Destinations
Table G: Recent Company Acquisitions in Cervical Cancer Diagnostics Market
Table H: HPV-Associated and HPV-Attributable Cancer Statistics, U.S, 2015
Table I: Major Players in cervical cancer diagnostics market in North America
Table J: Europe, Female Population aged 15+, By Region, 2017, (In Millions)
Table K: Major Players in cervical cancer diagnostics market in Europe
Table L: Pricing Analysis of PAP TEST
Table M: Pricing Analysis of HPV TEST
Table N: Pricing Analysis of Colposcopy Test
Table O: Pricing Analysis of Cervical Biopsy
Table P: Roche, Growth Strategy
Table Q: Product Benchmarking of Key Industry Players, By Type
Table R: Product Benchmarking of Key Industry Players, By Type
Table S: Recent Product Approvals of Key Industry Players in Cervical Cancer Diagnostics Market
Table A: List of Abbreviations
Table B: Cervical Cancer Flowchart
Table C: Cervical Cancer Screening Recommendations
Table D: Cervical Cancer Diagnostics Segmentation Flowchart
Table E: Medical Tourism Market Drivers
Table F: Medical Tourism Index, By Region and Top Destinations
Table G: Recent Company Acquisitions in Cervical Cancer Diagnostics Market
Table H: HPV-Associated and HPV-Attributable Cancer Statistics, U.S, 2015
Table I: Major Players in cervical cancer diagnostics market in North America
Table J: Europe, Female Population aged 15+, By Region, 2017, (In Millions)
Table K: Major Players in cervical cancer diagnostics market in Europe
Table L: Pricing Analysis of PAP TEST
Table M: Pricing Analysis of HPV TEST
Table N: Pricing Analysis of Colposcopy Test
Table O: Pricing Analysis of Cervical Biopsy
Table P: Roche, Growth Strategy
Table Q: Product Benchmarking of Key Industry Players, By Type
Table R: Product Benchmarking of Key Industry Players, By Type
Table S: Recent Product Approvals of Key Industry Players in Cervical Cancer Diagnostics Market
